The epidemic is outpacing us
In the forests and conflict zones of eastern Congo, a rare strain of Ebola is moving through communities faster than the world's health systems can follow. The Bundibugyo virus — seen only twice before in human history — has now claimed an estimated 220 lives among more than 900 suspected cases, in provinces where war has displaced tens of thousands and eroded the trust that containment depends upon. The World Health Organization has declared a global health emergency and its director-general is traveling to the region, but the honest assessment is this: the outbreak is ahead of the response, and the distance between them is still growing.
- The virus has already outrun early detection — with 900+ suspected cases against only 101 confirmed, the gap reveals how much ground was lost before health teams even arrived.
- Bundibugyo is among the rarest Ebola strains ever recorded, and unlike better-known variants, it has no approved vaccine and no approved treatment, leaving responders without their most powerful tools.
- Active conflict in Ituri and North Kivu has displaced over 100,000 people and put health facilities under direct attack, turning the geography of the outbreak into a battlefield that aid workers must navigate just to reach patients.
- Community distrust of outside health workers — hardened by years of violence and broken promises — allows the virus to move through populations with little resistance, even where responders manage to reach.
- The WHO has declared a Public Health Emergency of International Concern, neighboring Uganda has recorded confirmed spillover cases, and the agency's director-general is personally traveling to the DRC to accelerate a response he admits will worsen before it improves.
On Monday, the World Health Organization delivered its most direct warning yet about an Ebola outbreak tearing through the Democratic Republic of the Congo: the virus is moving faster than the response can contain it. WHO director-general Tedros Adhanom Ghebreyesus told a virtual ministerial briefing that while confirmed cases number 101 with 10 deaths, the suspected toll tells a far grimmer story — more than 900 cases and 220 deaths across the affected region. The gap between those two figures is itself a warning: the outbreak was detected late, and the virus had already spread well beyond the reach of health teams by the time they mobilized.
The strain is Bundibugyo virus, a form of Ebola so rare it has appeared in recorded history only twice before — Uganda in 2007, and the DRC in 2012. It is now spreading through Ituri and North Kivu, provinces shattered by intensified fighting that has displaced more than 100,000 people in recent months. Two health facilities were attacked last week alone. Insecurity compounds an already grave situation: communities in these regions carry deep mistrust of outside health workers, creating conditions where the virus can pass through populations with little resistance.
There are no approved vaccines for Bundibugyo virus. There are no approved therapeutics. The WHO has recommended two experimental monoclonal antibodies for urgent clinical trials, but these remain unproven at scale. Tedros was unsparing in his assessment — "It will get worse before it gets better" — while insisting the agency understands this virus and knows how to stop it, if the operational response can accelerate fast enough.
The outbreak was declared a public health emergency of international concern on May 17. Uganda has already recorded five confirmed cases and one death across its border. The WHO has rated national risk as "very high" and regional risk as "high," while urging neighboring countries to act immediately. Tedros is traveling to the DRC alongside the agency's emergencies director to oversee the response in person — a signal of how seriously the situation is being taken, and how much ground there is still left to recover.
On Monday, the World Health Organization delivered a stark assessment of an Ebola outbreak spreading through the Democratic Republic of the Congo: the virus is moving faster than the response can contain it. While confirmed cases stood at 101 with 10 deaths, the agency's director-general Tedros Adhanom Ghebreyesus laid out the fuller picture at a virtual ministerial briefing—more than 900 suspected cases and 220 suspected deaths across the affected region. The gap between confirmed and suspected numbers tells its own story: the outbreak was detected late, and by the time health teams mobilized, the virus had already moved ahead of them.
The strain circulating is Bundibugyo virus, a rare form of Ebola that has emerged only twice before in recorded history—once in Uganda in 2007, and once in the DRC in 2012. This time it is spreading in a region already fractured by conflict. The provinces of Ituri and North Kivu, where cases are concentrated, have been roiled by intensified fighting that has displaced more than 100,000 people in recent months. Two health facilities came under attack last week alone. The combination of insecurity and the deep mistrust communities hold toward outsiders—including health workers—creates conditions where the virus can move through populations with minimal resistance.
What makes this outbreak particularly difficult is the absence of proven medical countermeasures. There is no approved vaccine for Bundibugyo virus. There are no approved therapeutics. The WHO has recommended two monoclonal antibodies for urgent clinical trials, but these remain experimental. Tedros acknowledged the trajectory plainly: "It will get worse before it gets better." Yet he also offered a measured reassurance. The agency knows this virus. The agency knows how to stop it. The question is whether the operational response can accelerate fast enough to catch a moving target.
The outbreak was declared a public health emergency of international concern on May 17. Uganda, which shares a border with the DRC, has already recorded five confirmed cases and one death. The WHO has raised its assessment of national risk to "very high," while regional risk sits at "high" and global risk remains "low." Neighboring countries have been urged to take immediate action. Tedros is traveling to the DRC alongside the WHO's emergencies director to oversee the response directly. The agency is scaling up operations—deploying personnel, establishing surveillance systems, preparing treatment centers—but the fundamental challenge remains unchanged: an epidemic that is outpacing the machinery built to stop it.
Citas Notables
It will get worse before it gets better. But we know this virus, and we know how to stop it.— Tedros Adhanom Ghebreyesus, WHO director-general
La Conversación del Hearth Otra perspectiva de la historia
Why does the gap between confirmed and suspected cases matter so much here?
It's a measure of how long the virus had been spreading before anyone noticed. By the time you confirm a case, dozens more have already moved through the community undetected. That lag is where the outbreak gets away from you.
And the Bundibugyo strain—why is it harder to fight than other Ebolas?
Because we've barely seen it. We have no vaccine, no proven treatment. We're essentially learning as we go, while the virus spreads. The two times it emerged before, we contained it. But those were smaller, in different contexts. This time the ground itself is unstable.
The displacement of 100,000 people—does that help or hurt the virus?
Both. It scatters people across borders and into new communities, which spreads the virus. But it also means those people are in camps, in transit, in conditions where disease moves fast. And they're away from the health systems that might have caught cases earlier.
What does Tedros mean when he says "we know how to stop it"?
Isolation, contact tracing, safe burial practices, community engagement. These work. They've worked before. But they require trust, security, and time—three things the DRC doesn't have right now in those provinces.
Is there any scenario where this doesn't get worse?
Only if the response suddenly accelerates beyond what's currently happening. If security improves. If communities decide to cooperate. If the clinical trials show one of those antibodies works. But Tedros was being honest when he said it will worsen first.